皇冠体育寻求亚洲战略合作伙伴,皇冠代理招募中,皇冠平台开放会员注册、充值、提现、电脑版下载、APP下载。

首页体育正文

皇冠登录线路(www.hg108.vip):US Navy delivers first upgraded CN-235 plane to RMAF

admin2022-09-158

新2网址大全www.hg108.vip)实时更新发布最新最快最有效的新2网址和新2最新网址,包括新2手机网址,新2备用网址,皇冠最新网址,新2足球网址,新2网址大全。

The CN-235 is a medium-range twin-engine transport aircraft manufactured by the Indonesian aerospace company PT Dirgantara and Construcciones Aeronáuticas SA of Spain. – Twitter pic, August 7, 2022.

THE US Navy has delivered the first of three Royal Malaysian Air Force (RMAF) CN-235 transport aircraft converted to a maritime patrol platform.

This comes just three-and-a-half years after the US signed a letter of offer and acceptance to begin increasing the capability and interoperability of US and Malaysian forces.

In a statement, the US Navy said the effort was facilitated by the US Navy’s Building Partner Capacity programme, aligned with the US government’s Maritime Security Initiative.

The initiative is intended to assist the Malaysian government in increasing maritime security and maritime domain awareness within the Malaysian Exclusive Economic Zone.

,

皇冠登录线路www.hg108.vip)实时更新发布最新最快的皇冠手机网址、皇冠手机网址线路、皇冠手机网址登录网址、皇冠手机网址管理端、皇冠手机网址手机版登录网址、新2手机皇冠登录网址。

,

“The Malaysian CN-235 programme will be a significant force multiplier to an indigenous Malaysian intelligence, surveillance and reconnaissance capability,” its Security Cooperation Office at the Naval Air Systems Command director, Ron Weinberger, said.

He said this will directly support joint Malaysian and US efforts to ensure global security in the Indo-Pacific Command area of responsibility.

The project’s CN-235s were flown to Indonesia for completion and testing in September 2020 amid Covid-19 restrictions, and the first flight took place last October.

Work on the two remaining CN-235 aircraft and multiple ground stations continues and is expected to be completed this year, the statement read.

The CN-235 is a medium-range twin-engine transport aircraft manufactured by the Indonesian aerospace company PT Dirgantara and Construcciones Aeronáuticas SA of Spain. – Bernama, August 7, 2022.


转载说明:本文转载自Sunbet。

网友评论

1条评论
  • 2022-09-15 00:10:31

    【环球网记者 陈超】凯因科技是一家以生物技术为平台,专注于病毒性疾病领域,致力于提供治疗解决方案的生物医药公司。资料显示,公司科创板IPO申请本周将上会审核。公司此次计划发行不超过4246万股,占发行后总股本的比例不超过25%。预计募资规模为10.92亿元,其中7.48亿元用于新药研发,0.44亿元用于营销网络扩建,另有3亿元用于补充流动资金。,由于凯因科技多项在研药品涉及乙肝、新型冠状病毒病、流感领域,因此公司上会备受关注。不过,凯因科技招股书透露出的公司重销售轻研发、核心员工兼职经营关联企业,以及涉嫌虚假股东会等一系列问题也让公司上市前景并不明朗。不错呢,喜欢你